Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rock Creek Pharmaceuticals Inc (NASDAQ:RCPI)

1.18
Delayed Data
As of Jul 31
 -0.08 / -6.35%
Today’s Change
1.12
Today|||52-Week Range
13.25
-74.07%
Year-to-Date
SECTOR
Consumer Non-Durables
INDUSTRY
Household/Personal Care
MARKET CAP
$11.9M

Company Description

Rock Creek Pharmaceuticals, Inc. is a pharmaceutical development company, which focuses on the discovery, development, and commercialization of therapies for chronic inflammatory disease, neurologic disorders, and behavioral health utilizing its proprietary compounds. The company also focuses on pharmaceutical development activities centered primarily on anatabine citrate as a lead drug candidate. The company was founded by Williams Jonnie in 1991 and is headquartered in Glen Allen, VA. Rock Creek Pharmaceuticals, Inc. is a pharmaceutical development company, which focuses on the discovery, development, and commercialization of therapies for chronic inflammatory disease, neurologic disorders, and behavioral health utilizing its proprietary compounds. The company also focuses on pharmaceutical development activities centered primarily on anatabine citrate as a lead drug candidate. The company was founded by Williams Jonnie in 1991 and is headquartered in Glen Allen, VA.

Contact Information

Rock Creek Pharmaceuticals, Inc.
2040 Whitfield Avenue
Sarasota Florida 34243
P:(804) 527-1970
Investor Relations:

Employees

Shareholders

Other institutional9.66%
Mutual fund holders2.08%
Individual stakeholders0.05%

Top Executives

Michael John MullanChairman, President & Chief Executive Officer
Benjamin M. DentCFO, Secretary, Treasurer & VP-Operations
Curtis WrightSenior Vice President-Medical & Clinical Director
Ryan K. LanierChief Scientific Officer
Theodore JenkinsVice President-Corporate Strategy & Development